Batch # sr-bpctb-260316-001BPC+TB Blend 20mg

20mg Active

Independent lab report COA-2026–GYDKD (analyzed 05/11/2026): 99.94% HPLC purity, 21.17 mg net peptide content, identity confirmed, heavy metals not detected, sterility screen no growth, endotoxin NMT 0.05 EU/mL, fentanyl not tested.

Verify this report Download the report (PDF)

Independent lab report

Commissioned by Source Research from an independent lab, separate from the supplier. Values below are copied from the report as printed.

Testing lab: ILS Laboratories
COA #: COA-2026–GYDKD
Batch #: sr-bpctb-260316-001
Accession #: ACC-2026-2099
Analysis date: 05/11/2026
Date received: 05/06/2026
Labeled content (as submitted): 20mg
Method: Full QC Panel
Appearance: Good
Vials tested: 1 of 10
Fentanyl: Not tested
Overall result (as printed): PASS

Full QC panel
Analyte	Specification	Result	Status
Purity (HPLC)	>= 95.0%	99.94%	PASS
Net Peptide Content	Report Only	21.17 mg	N/A
Identity (ID)	BPC-157; TB-4	Confirmed	PASS

Heavy metals (ICP-MS)
Test	Specification	Result	Status
Arsenic (As)	NMT 1.5 ppm	Not Detected	PASS
Cadmium (Cd)	NMT 0.5 ppm	Not Detected	PASS
Chromium (Cr)	NMT 10 ppm	Not Detected	PASS
Mercury (Hg)	NMT 1.5 ppm	Not Detected	PASS
Lead (Pb)	NMT 1 ppm	Not Detected	PASS

Sterility (PCR)
Test	Specification	Result	Status
Sterility (PCR)	No Growth	No Growth	PASS

Endotoxin (USP <85>)
Test	Specification	Result	Status
Endotoxin (USP <85>)	< 0.25 EU/mL	NMT 0.05 EU/mL	PASS

Fentanyl: not tested. This report does not include a fentanyl screen.

Methods, as stated in the report

Identity confirmed by HPLC: chromatographic retention time comparison with a reference standard.
Elemental impurities analyzed by ICP-MS per USP <233> methodology. Acceptance criteria are internal laboratory quality screening limits for research-use materials.

Report links: Verify page · PDF

Supplier COA

No supplier COA is published for this lot.

All BPC+TB Blend 20mg lots · All testing records

For laboratory research use only. Results relate only to the sample tested.